The Successful Career Of Mikhail Blagosklonny
Mikhail Blagosklonny is cancer and aging researcher at the Roswell Park Cancer Institute. The scientist is also a professor of oncology at the Institute. He resides in New York.
Blagosklonny has a sound educational background. He studied M.D in internal medicine at the First Pavlov State Medical University of St. Petersburg. His desire to learn more in the field saw him enroll for a doctorate in experimental medicine and cardiology at the same university.
After completing his doctorate degree, he was appointed by the New York Medical College as an associate professor of medicine. He served at the college for some time. In 2002, he moved to Ordway Research Institute. At Ordway, he worked as a senior scientist. In this facility, which is located in Albany, New York, he was charged with researching on aging and cancer on researchgate.com. After seven years working at the Institute, he went to serve as an oncology professor at Roswell Park Cancer Institute. He has worked at this institution since then.
The Roswell Park Cancer Institute believes that Mikhail Blagosklonny will ignite the research works already going at the institute and provide a new point of view. At Roswell, Blagosklonny has played a pivotal role in furthering human’s knowledge on cancer. He primarily researches on cancer, targeted cancer therapies, how to protect healthy cells, and the underlying mechanisms of aging. He also studies how cancer drugs can be used to treat aging.
Recently, the scientist formulated a hypothesis on TOR signaling and aging. His hypothesis claimed that TOR signaling plays a critical role in aging and cancer. If it is true, it means that cancer drugs such as rapamycin could be used as a possible treatment for life extension. He is one of the main supporters of the drug. Mikhail has called for other scientists to research further into the idea on tandonline.com.
The scientist is an editor. He is associated with Cell Cycle, Aging, and Oncotarget. He is the editor-in-chief of these journals. Blagosklonny is also Cancer Biology & Therapy’s associate editor. Moreover, he is actively involved in the editorial board of Cell Death & Differentiation.
Mikhail Blagosklonny is also the author of over 270 articles. His papers have been published in many peer-reviewed journals. In addition, he has over 25,000 citations. This high number of citations has earned him an h-index of 83. Some of his publications include “Oncogenic Resistance to Growth-Limiting Conditions’ and ‘Conceptual Biology: Unearthing the Gems.’ Mikhail’s works have been published in authoritative journals such as Nature Review Cancer, Nature Leukemia, and Autophagy.